<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00738686</url>
  </required_header>
  <id_info>
    <org_study_id>AUTAX</org_study_id>
    <nct_id>NCT00738686</nct_id>
  </id_info>
  <brief_title>Austrian Multivessel Taxus-Stent Registry</brief_title>
  <acronym>AUTAX</acronym>
  <official_title>Austrian Multivessel Taxus-Stent Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of AUTAX study is to investigate the frequency of MACCE in patients with multivessel
      disease and multiple Taxus stent implantations in the &quot;real world&quot; stenting at 30 days, 6 and
      12 months at 2 year follow-up. Because multivessel stenting using DES has been limited due to
      economic considerations, the secondary aim is to enhance experience in multivessel stenting
      with drug-eluting stents in order to improve short- and long-term outcomes of the patients
      with severe multiple coronary artery stenoses.

      The objectives of the study are:

        1. To determine the frequency of MACCE at 30-day, 6 and 12-month and at 2 year clinical
           follow-up after multivessel intervention with drug-eluting stents in a prospective
           patient cohort..

        2. To determine the rate of in-stent restenosis, target lesion and target vessel
           revascularization (angiographic measures) 6 months in patients with multiple DESs in
           multiple lesions.

        3. To investigate the clinical and angiographic outcomes after implantation of multiple
           DESs in the subgroup of patients with accompanying diseases (diabetes mellitus, renal
           insufficiency) with known high restenosis and late complication rate.

        4. To evaluate potential cost burden in attempting a strategy of complete revascularization
           by multiple DES in patients with multivessel disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2004</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of MACCE, defined as all-cause death, nonfatal acute myocardial infarction (AMI) target vessel revascularization (TVR) and cerebrovascular event during the two-year clinical follow-up (FUP)</measure>
    <time_frame>2 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Break-down primary endpoints at the 2-year FUP, as the rate of TVR, non-fatal AMI, all-cause death, stroke and the composite of death and AMI</measure>
    <time_frame>2 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of 30-days, 6-mo and 1-year MACCE</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute, subacute and late thrombosis rates</measure>
    <time_frame>2 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic end-points as the binary restenosis rate per lesion (defined as diameters stenosis â‰¥ 50%), in-stent and proximal and distal in-lesion late lumen loss</measure>
    <time_frame>6-month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">441</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single-arm study, no placebo or control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intracoronary stent implantation</intervention_name>
    <description>Taxus stent implantation in patients with multivessel coronary artery disease</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Taxus Express</other_name>
    <other_name>Taxus Liberte</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic coronary multivessel disease

          -  possible percutaneous complete coronary revascularization

          -  age &gt;18 year

          -  significant coronary lesion at least in 2 vessels

        Exclusion Criteria:

          -  acute myocardial infarction within 48 hours

          -  contraindications to clopidogrel, aspirin, heparin and taxol

          -  pregnancy or lack of protection against pregnancy or breast-feeding during the study

          -  hemorrhagic diathesis

          -  platelet count &lt;100.000/ml3
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helmut-Dietmar Glogar, MD FESC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. Cardiology, Medical University of Vienna, Vienna, Austria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Landeskrankenhaus</name>
      <address>
        <city>Bruck an der Mur</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Interventional Cardiology, Academic Hospital</name>
      <address>
        <city>Feldkirch</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landeskrankenhaus Graz-West</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus der Stadt Linz</name>
      <address>
        <city>Linz</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Barmherzigen Schwestern</name>
      <address>
        <city>Linz</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Johannes Spital</name>
      <address>
        <city>Salzburg</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rudolfstiftung</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2008</study_first_submitted>
  <study_first_submitted_qc>August 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2008</study_first_posted>
  <last_update_submitted>August 20, 2008</last_update_submitted>
  <last_update_submitted_qc>August 20, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2008</last_update_posted>
  <responsible_party>
    <name_title>Helmut-Dietmar Glogar</name_title>
    <organization>Dept. Cardiology, Medical University of Vienna, Austria</organization>
  </responsible_party>
  <keyword>coronary artery disease</keyword>
  <keyword>drug-eluting stent</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <keyword>major adverse cardiac event</keyword>
  <keyword>in-stent restenosis</keyword>
  <keyword>stent thrombosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

